Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

A train the trainer program for healthcare professionals tasked with providing psychosocial support to breast cancer survivors

Authors: Eunyoung Park, Junghee Yoon, Eun-kyung Choi, Im Ryung Kim, Danbee Kang, Se-Kyung Lee, Jeong Eon Lee, Seok Jin Nam, Jin Seok Ahn, Adriaan Visser, Juhee Cho

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

The objective of this study is to develop, implement, and evaluate a training program for healthcare providers to improve ability to provide psychosocial support to breast cancer survivors in Korea.

Methods

Based on a needs assessment survey and in-depth interviews with breast cancer survivors, a multidisciplinary team developed two-day intensive training program as well as education materials and counseling notes. Participants’ overall satisfaction was evaluated after the training.

Results

The training program included a total of 16 lectures held over the course of seven sessions. Forty-one nurses and 3 social workers participated in the training program. Mean age was 37.5(± 6.4) years, and on average, they had 11.1 (± 5.6) years of experience. Participants’ overall satisfaction was good as following: program contents (4.04), trainee guidebook (3.82), location and environment (4.10), and program organization (4.19). Among the participants, 31 (70.4%) received certification after submitting real consultation cases after the training.

Conclusion

Two day intensive training can provide a comprehensive and coordinated education to healthcare professionals for implementing survivorship care with an emphasis on psychosocial support. Furthermore, the program should resume as a periodic continuing education course for healthcare providers. Similar education for graduate students in oncology nursing would be beneficial.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012;30(11):1215–20.CrossRefPubMed
4.
Cheung YT, et al. Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol. 2012;23(10):2547–52.CrossRefPubMed
5.
Zebrack BJ, et al. The impact of cancer and quality of life for long-term survivors. Psychooncology. 2008;17(9):891–900.CrossRefPubMed
6.
Cho J, et al. Public attitudes toward cancer and cancer patients: a national survey in Korea. Psychooncology. 2013;22(3):605–13.CrossRefPubMed
7.
Costanzo ES, et al. Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer. 2007;97(12):1625–31.CrossRefPubMedPubMedCentral
8.
Matthews H, Grunfeld EA, Turner A. The efficacy of interventions to improve psychosocial outcomes following surgical treatment for breast cancer: a systematic review and meta-analysis. Psychooncology. 2017;26(5):593–607.CrossRefPubMed
9.
Park BW, Hwang SY. Unmet needs of breast cancer patients relative to survival duration. Yonsei Med J. 2012;53(1):118–25.CrossRefPubMed
10.
11.
Uitterhoeve RJ, et al. The effect of communication skills training on patient outcomes in cancer care: a systematic review of the literature. Eur J Cancer Care (Engl). 2010;19(4):442–57.CrossRef
12.
Sheldon LK. An evidence-based communication skills training programme for oncology nurses improves patient-centred communication, enhancing empathy, reassurance and discussion of psychosocial needs. Evid Based Nurs. 2011;14(3):87–8.CrossRefPubMed
13.
Blasco PG, et al. Using movie clips to foster learners’ reflection: improving education in the affective domain. Fam Med. 2006;38(2):94–6.PubMed
14.
Caruana CJ, et al. A comprehensive SWOT audit of the role of the biomedical physicist in the education of healthcare professionals in Europe. Phys Med. 2010;26(2):98–110.CrossRefPubMed
15.
Peairs KS, et al. Coordination of care in breast cancer survivors: an overview. J Support Oncol. 2011;9(6):210–5.CrossRefPubMed
16.
Hewitt M, Sheldon G, Stovall E, editors. Committee on cancer survivorship: improving care and quality of life, National Cancer Policy Board, Institute of Medicine and National Research Council, From patient to cancer survivor: lost in transition. Washington DC: The National Academies Press; 2005.
17.
18.
19.
Kantsiper M, et al. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24(Suppl 2):S459–66.CrossRefPubMed
20.
Davies NJ, Batehup L. Towards a personalised approach to aftercare: a review of cancer follow-up in the UK. J Cancer Surviv. 2011;5(2):142–51.CrossRefPubMed
21.
Holland J, Watson M, Dunn J. The IPOS new international standard of quality cancer care: integrating the psychosocial domain into routine care. Psychooncology. 2011;20(7):677–80.CrossRefPubMed
22.
Jacobsen PB. Clinical practice guidelines for the psychosocial care of cancer survivors: current status and future prospects. Cancer. 2009;115(18 Suppl):4419–29.CrossRefPubMed
23.
Smith SL, et al. Survivors of breast cancer: patient perspectives on survivorship care planning. J Cancer Surviv. 2011;5(4):337–44.CrossRefPubMed
24.
Johnson J. An overview of psychosocial support services. Resources for healing. Cancer Nurs. 2000;23(4):310–3.CrossRefPubMed
25.
Haq R, et al. Designing a multifaceted survivorship care plan to meet the information and communication needs of breast cancer patients and their family physicians: results of a qualitative pilot study. BMC Med Inform Decis Mak. 2013;13:76.CrossRefPubMedPubMedCentral
26.
Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;24(32):5112–6.CrossRefPubMed
27.
Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26(5):759–67.CrossRefPubMed
28.
Metadata
Title
A train the trainer program for healthcare professionals tasked with providing psychosocial support to breast cancer survivors
Authors
Eunyoung Park
Junghee Yoon
Eun-kyung Choi
Im Ryung Kim
Danbee Kang
Se-Kyung Lee
Jeong Eon Lee
Seok Jin Nam
Jin Seok Ahn
Adriaan Visser
Juhee Cho
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3965-2

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

Effects of PKM2 on global metabolic changes and prognosis in hepatocellular carcinoma: from gene expression to drug discovery

Study protocol

Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: study protocol of a randomised controlled trial to evaluate the effect of short message service (SMS) reminder

Correction

Correction to: Daphnane diterpenes inhibit the metastatic potential of B16F10 murine melanoma cells in vitro and in vivo

Research article

Domain-specific physical activity and the risk of colorectal cancer: results from the Melbourne Collaborative Cohort Study

Research article

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

Research article

CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits